Bloomberg -- Breast implant-linked lymphoma can be controlled by removing the implant and the surrounding tissue, researchers said. The industry-funded study by the Rand Corp. is based on a review of 29 cases of a rare form of immune-system cancer in breast-implant patients and input from a panel of experts.